Vascular and Metabolic Effects of Vytorin

• Status: Completed
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigator hypothesize that vytorin may improve vascular and insulin resistance in hypercholesterolemic patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gachon University Gil Medical Center
• Treatments: Ezetimibe, Simvastatin Drug Combination

Criteria

Inclusion Criteria:

• hypercholesterolemia

Exclusion Criteria:

• overt liver disease, chronic renal failure, hypothyroidism, myopathy, uncontrolled diabetes (HbA1c > 9%), severe hypertension, stroke, acute coronary events, coronary revascularization within the preceding 3 months, or alcohol abuse